Literature DB >> 32439761

Core Hippo pathway components act as a brake on Yap and Taz in the development and maintenance of the biliary network.

Zachary J Brandt1, Ashley E Echert1, Jonathan R Bostrom1, Paula N North2, Brian A Link3.   

Abstract

The development of the biliary system is a complex yet poorly understood process, with relevance to multiple diseases, including biliary atresia, choledochal cysts and gallbladder agenesis. We present here a crucial role for Hippo-Yap/Taz signaling in this context. Analysis of sav1 mutant zebrafish revealed dysplastic morphology and expansion of both intrahepatic and extrahepatic biliary cells, and ultimately larval lethality. Biliary dysgenesis, but not larval lethality, is driven primarily by Yap signaling. Re-expression of Sav1 protein in sav1 -/- hepatocytes is able to overcome these initial deficits and allows sav1 -/- fish to survive, suggesting cell non-autonomous signaling from hepatocytes. Examination of sav1 -/- rescued adults reveals loss of gallbladder and formation of dysplastic cell masses expressing biliary markers, suggesting roles for Hippo signaling in extrahepatic biliary carcinomas. Deletion of stk3 revealed that the phenotypes observed in sav1 mutant fish function primarily through canonical Hippo signaling and supports a role for phosphatase PP2A, but also suggests Sav1 has functions in addition to facilitating Stk3 activity. Overall, this study defines a role for Hippo-Yap signaling in the maintenance of both intra- and extrahepatic biliary ducts.
© 2020. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Cholangiocarcinoma; Gallbladder; Hepatopancreatic ductal system; Hippo pathway; Sav1; Stk3

Mesh:

Substances:

Year:  2020        PMID: 32439761      PMCID: PMC7328147          DOI: 10.1242/dev.184242

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  60 in total

1.  The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis.

Authors:  Fisun Hamaratoglu; Maria Willecke; Madhuri Kango-Singh; Riitta Nolo; Eric Hyun; Chunyao Tao; Hamed Jafar-Nejad; Georg Halder
Journal:  Nat Cell Biol       Date:  2005-12-11       Impact factor: 28.824

2.  Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors.

Authors:  A I McClatchey; I Saotome; K Mercer; D Crowley; J F Gusella; R T Bronson; T Jacks
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

3.  Restriction of hepatic competence by Fgf signaling.

Authors:  Donghun Shin; Yoonsung Lee; Kenneth D Poss; Didier Y R Stainier
Journal:  Development       Date:  2011-04       Impact factor: 6.868

4.  Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver.

Authors:  Samira Benhamouche; Marcello Curto; Ichiko Saotome; Andrew B Gladden; Ching-Hui Liu; Marco Giovannini; Andrea I McClatchey
Journal:  Genes Dev       Date:  2010-07-30       Impact factor: 11.361

5.  Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.

Authors:  Jing Yi; Li Lu; Kilangsungla Yanger; Wenqi Wang; Bo Hwa Sohn; Ben Z Stanger; Min Zhang; James F Martin; Jaffer A Ajani; Junjie Chen; Ju-Seog Lee; Shumei Song; Randy L Johnson
Journal:  Hepatology       Date:  2016-09-30       Impact factor: 17.425

6.  The Hippo pathway effector Wwtr1 regulates cardiac wall maturation in zebrafish.

Authors:  Jason K H Lai; Michelle M Collins; Veronica Uribe; Vanesa Jiménez-Amilburu; Stefan Günther; Hans-Martin Maischein; Didier Y R Stainier
Journal:  Development       Date:  2018-05-17       Impact factor: 6.868

7.  The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.

Authors:  Nailing Zhang; Haibo Bai; Karen K David; Jixin Dong; Yonggang Zheng; Jing Cai; Marco Giovannini; Pentao Liu; Robert A Anders; Duojia Pan
Journal:  Dev Cell       Date:  2010-07-20       Impact factor: 12.270

8.  LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development.

Authors:  Da-Hye Lee; Jae Oh Park; Tae-Shin Kim; Sang-Kyum Kim; Tack-Hoon Kim; Min-Chul Kim; Gun Soo Park; Jeong-Hwan Kim; Shinji Kuninaka; Eric N Olson; Hideyuki Saya; Seon-Young Kim; Ho Lee; Dae-Sik Lim
Journal:  Nat Commun       Date:  2016-06-30       Impact factor: 14.919

9.  Regulation of posterior body and epidermal morphogenesis in zebrafish by localized Yap1 and Wwtr1.

Authors:  Natalie L Smith; Jason Kuan Han Lai; David Kimelman; Didier Yr Stainier
Journal:  Elife       Date:  2017-12-28       Impact factor: 8.140

10.  SAV1 promotes Hippo kinase activation through antagonizing the PP2A phosphatase STRIPAK.

Authors:  Sung Jun Bae; Lisheng Ni; Adam Osinski; Diana R Tomchick; Chad A Brautigam; Xuelian Luo
Journal:  Elife       Date:  2017-10-24       Impact factor: 8.140

View more
  3 in total

Review 1.  Role of YAP1 Signaling in Biliary Development, Repair, and Disease.

Authors:  Laura Molina; Kari Nejak-Bowen; Satdarshan P Monga
Journal:  Semin Liver Dis       Date:  2022-01-24       Impact factor: 6.512

2.  Novel zebrafish polycystic kidney disease models reveal functions of the Hippo pathway in renal cystogenesis.

Authors:  Zhiqin Ren; Zhiwei Zhang; Tzu-Ming Liu; Wei Ge
Journal:  Dis Model Mech       Date:  2021-11-09       Impact factor: 5.758

Review 3.  The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer.

Authors:  Richard Cunningham; Carsten Gram Hansen
Journal:  Clin Sci (Lond)       Date:  2022-02-11       Impact factor: 6.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.